Month: January 2023

2024.07.17
Summary of the most important events and achievements of the Genomtec S.A.

2024.06.25
Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Archive

2023.01.25

Polish Financial Supervision Authority approved the Genomtec S.A. prospectus

In the next few days, the company expects to apply to the Warsaw Stock Exchange for admission and listing of Genomtec S.A. shares on the Warsaw ...
Read
2023.01.10

Value of the intellectual property portfolio of Genomtec S.A. estimated at EUR 191.336 million

Genomtec S.A. received from the German company Dennemeyer Consulting GmbH a valuation of the Company’s intellectual property portfolio. ...
Read

Archive